Imexpharm Corporation announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced total revenue was VND 487,015.000 million compared to VND 516,073.000 million a year ago. Operating income was VND 87,704.609 million compared to VND 64,884.241 million a year ago. Net income was VND 70,378.370 million compared to VND 51,936.264 million a year ago. Basic earnings per share from continuing operations was VND 931 compared to VND 925 a year ago. For the full year, total revenue was VND 1,369,420.000 million compared to VND 1,402,450.000 million a year ago. Operating income was VND 252,540.000 million compared to VND 194,427.000 million a year ago. Net income was VND 209,697.000 million compared to VND 162,387.000 million a year ago. Basic earnings per share from continuing operations was VND 2,773 compared to VND 2,892 a year ago.